Published in Brain Res Bull on November 01, 1998
Transcription factor E2F-associated phosphoprotein (EAPP), RAM2/CDCA7L/JPO2 (R1), and simian virus 40 promoter factor 1 (Sp1) cooperatively regulate glucocorticoid activation of monoamine oxidase B. Mol Pharmacol (2010) 0.98
Elevated monoamine oxidase a binding during major depressive episodes is associated with greater severity and reversed neurovegetative symptoms. Neuropsychopharmacology (2013) 0.85
Comparative neuroprotective effects of rasagiline and aminoindan with selegiline on dexamethasone-induced brain cell apoptosis. Neurotox Res (2009) 0.84
The New Inhibitor of Monoamine Oxidase, M30, has a Neuroprotective Effect Against Dexamethasone-Induced Brain Cell Apoptosis. Front Neurosci (2010) 0.81
The impact of agricultural soil erosion on the global carbon cycle. Science (2007) 3.74
Modeling the developmental neurotoxicity of chlorpyrifos in vitro: macromolecule synthesis in PC12 cells. Toxicol Appl Pharmacol (1998) 2.58
Developmental neurotoxicity of chlorpyrifos: cellular mechanisms. Toxicol Appl Pharmacol (1995) 2.47
Cellular mechanisms for developmental toxicity of chlorpyrifos: targeting the adenylyl cyclase signaling cascade. Toxicol Appl Pharmacol (1997) 2.42
Metabolic oxidation phenotypes as markers for susceptibility to lung cancer. Nature (1984) 2.17
Persistent behavioral consequences of neonatal chlorpyrifos exposure in rats. Brain Res Dev Brain Res (2001) 1.90
Chlorpyrifos interferes with cell development in rat brain regions. Brain Res Bull (1997) 1.88
Chlorpyrifos elicits mitotic abnormalities and apoptosis in neuroepithelium of cultured rat embryos. Teratology (1998) 1.83
Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency. Neurology (2007) 1.81
Developmental neurotoxicity of chlorpyrifos: delayed targeting of DNA synthesis after repeated administration. Brain Res Dev Brain Res (1998) 1.60
Chlorpyrifos exposure during a critical neonatal period elicits gender-selective deficits in the development of coordination skills and locomotor activity. Brain Res Dev Brain Res (2000) 1.58
Developmental neurotoxicity of chlorpyrifos modeled in vitro: comparative effects of metabolites and other cholinesterase inhibitors on DNA synthesis in PC12 and C6 cells. Environ Health Perspect (2001) 1.57
Apolipoprotein E-epsilon 4 frequency in geriatric depression. Biol Psychiatry (1996) 1.56
An animal model of adolescent nicotine exposure: effects on gene expression and macromolecular constituents in rat brain regions. Brain Res (2000) 1.51
Novel binding mode of highly potent HIV-proteinase inhibitors incorporating the (R)-hydroxyethylamine isostere. J Med Chem (1991) 1.50
Early biochemical detection of delayed neurotoxicity resulting from developmental exposure to chloropyrifos. Brain Res Bull (1998) 1.48
Neonatal chlorpyrifos exposure alters synaptic development and neuronal activity in cholinergic and catecholaminergic pathways. Brain Res Dev Brain Res (1999) 1.48
Adolescent nicotine exposure causes persistent upregulation of nicotinic cholinergic receptors in rat brain regions. Brain Res (1999) 1.40
Persistent cholinergic presynaptic deficits after neonatal chlorpyrifos exposure. Brain Res (2001) 1.39
Fetal and adolescent nicotine administration: effects on CNS serotonergic systems. Brain Res (2001) 1.36
Developmental neurotoxicity of chlorpyrifos in vivo and in vitro: effects on nuclear transcription factors involved in cell replication and differentiation. Brain Res (2000) 1.34
Adrenomedullary function in the neonatal rat: responses to acute hypoxia. J Physiol (1985) 1.32
Connective tissue activation. XIV. Composition and actions of a human platelet autacoid mediator. Arthritis Rheum (1979) 1.30
Functional alterations in CNS catecholamine systems in adolescence and adulthood after neonatal chlorpyrifos exposure. Brain Res Dev Brain Res (2002) 1.29
Beta-adrenoceptor signaling and its control of cell replication in MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat (2000) 1.25
Adolescent nicotine exposure produces immediate and long-term changes in CNS noradrenergic and dopaminergic function. Brain Res (2001) 1.21
Is oxidative stress involved in the developmental neurotoxicity of chlorpyrifos? Brain Res Dev Brain Res (2000) 1.20
Connective tissue activation. XI. Stimulation of glycosaminoglycan and DNA formation by a platelet factor. Arthritis Rheum (1977) 1.15
Adrenomedullary catecholamine release in the fetus and newborn: secretory mechanisms and their role in stress and survival. J Dev Physiol (1988) 1.13
Effects of prenatal nicotine exposure on development of central and peripheral cholinergic neurotransmitter systems. Evidence for cholinergic trophic influences in developing brain. J Pharmacol Exp Ther (1989) 1.13
Toxicological implications of polymorphic drug metabolism. Ciba Found Symp (1980) 1.11
Impaired cardiac function during postnatal hypoxia in rats exposed to nicotine prenatally: implications for perinatal morbidity and mortality, and for sudden infant death syndrome. Teratology (1997) 1.10
Perinatal exposure to environmental tobacco smoke upregulates nicotinic cholinergic receptors in monkey brain. Brain Res Dev Brain Res (2002) 1.09
Prenatal exposure to nicotine impairs nervous system development at a dose which does not affect viability or growth. Brain Res Bull (1989) 1.09
Persistent and delayed behavioral changes after nicotine treatment in adolescent rats. Brain Res (2000) 1.06
Nicotine evokes cell death in embryonic rat brain during neurulation. J Pharmacol Exp Ther (1998) 1.05
Neonatal chlorpyrifos exposure targets multiple proteins governing the hepatic adenylyl cyclase signaling cascade: implications for neurotoxicity. Brain Res Dev Brain Res (2000) 1.05
Abnormalities of connective tissue cells cultured from patients with rheumatoid arthritis. II. Defective regulation of hyaluronate and collagen formation. J Lab Clin Med (1971) 1.05
Loss of neonatal hypoxia tolerance after prenatal nicotine exposure: implications for sudden infant death syndrome. Brain Res Bull (1995) 1.05
Neuroinflammation and behavioral abnormalities after neonatal terbutaline treatment in rats: implications for autism. J Pharmacol Exp Ther (2007) 1.05
Ontogeny of adrenomedullary responses to hypoxia and hypoglycemia: role of splanchnic innervation. Brain Res Bull (1986) 1.05
Regulation of collagen and hyaluronate formation in human synovial fibroblast cultures. J Lab Clin Med (1970) 1.03
Modeling adolescent nicotine exposure: effects on cholinergic systems in rat brain regions. Brain Res (2000) 1.02
Nutritional influences on adrenal chromaffin cell development: comparison with central neurons. Pediatr Res (1988) 1.02
Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease. Evidence from rapid autopsy studies. J Clin Invest (1994) 1.01
The corticotropin-releasing hormone test in patients with posttraumatic stress disorder. Biol Psychiatry (1989) 1.01
Alterations in serotonin transporter expression in brain regions of rats exposed neonatally to chlorpyrifos. Brain Res Dev Brain Res (2001) 0.97
Serotonin transporter expression in rat brain regions and blood platelets: aging and glucocorticoid effects. Biol Psychiatry (1997) 0.97
Paroxetine in human breast milk and nursing infants. Am J Psychiatry (2000) 0.96
Deficits in development of central cholinergic pathways caused by fetal nicotine exposure: differential effects on choline acetyltransferase activity and [3H]hemicholinium-3 binding. Neurotoxicol Teratol (1993) 0.95
Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit. J Mol Cell Cardiol (1997) 0.95
Modeling the pharmacokinetics and pharmacodynamics of dexamethasone in depressed patients. Eur J Clin Pharmacol (1992) 0.94
Adolescent nicotine administration alters serotonin receptors and cell signaling mediated through adenylyl cyclase. Brain Res (2002) 0.94
Retrospective analysis of sequential changes in serum intact parathyroid hormone levels during conventional parathyroid exploration. Surgery (1999) 0.94
Amniotic fluid and umbilical cord blood concentrations of antidepressants in three women. Biol Psychiatry (2000) 0.94
5 alpha-pregnane-3 alpha, 21-diol-20-one (THDOC) attenuates mild stress-induced increases in plasma corticosterone via a non-glucocorticoid mechanism: comparison with alprazolam. Brain Res (1992) 0.93
Human immunodeficiency virus glycoprotein (gp120) infused into rat brain induces interleukin 1 to elevate pituitary-adrenal activity and decrease peripheral cellular immune responses. Proc Natl Acad Sci U S A (1991) 0.93
Effects of prenatal nicotine exposure on biochemical development of rat brain regions: maternal drug infusions via osmotic minipumps. J Pharmacol Exp Ther (1987) 0.93
Brain IL-1-induced immunosuppression occurs through activation of both pituitary-adrenal axis and sympathetic nervous system by corticotropin-releasing factor. J Neurosci (1990) 0.93
Ontogeny of histaminergic neurotransmission in the rat brain: concomitant development of neuronal histamine, H-1 receptors, and H-1 receptor-mediated stimulation of phospholipid turnover. J Neurochem (1981) 0.93
Fetal dexamethasone exposure accelerates development of renal function: relationship to dose, cell differentiation and growth inhibition. J Dev Physiol (1992) 0.92
Prenatal exposure to nicotine via maternal infusions: effects on development of catecholamine systems. J Pharmacol Exp Ther (1988) 0.92
Inhibition of DNA synthesis in neonatal rat brain regions caused by acute nicotine administration. Brain Res Dev Brain Res (1991) 0.90
Ontogeny of cardiac beta-adrenoceptor desensitization mechanisms: agonist treatment enhances receptor/G-protein transduction rather than eliciting uncoupling. J Mol Cell Cardiol (1999) 0.90
Modeling geriatric depression in animals: biochemical and behavioral effects of olfactory bulbectomy in young versus aged rats. J Pharmacol Exp Ther (1999) 0.89
Plasma dexamethasone concentration and cortisol response during manic episodes. Biol Psychiatry (1998) 0.89
A pilot study of a structured interview addressing sexual function in men with schizophrenia. Biol Psychiatry (1994) 0.89
Fetal dexamethasone exposure interferes with establishment of cardiac noradrenergic innervation and sympathetic activity. Teratology (1993) 0.89
Cardiac alpha-adrenergic receptor expression is regulated by thyroid hormone during a critical developmental period. J Mol Cell Cardiol (1996) 0.89
Programming of brainstem serotonin transporter development by prenatal glucocorticoids. Brain Res Dev Brain Res (1996) 0.88
Regulatory changes in presynaptic cholinergic function assessed in rapid autopsy material from patients with Alzheimer disease: implications for etiology and therapy. Proc Natl Acad Sci U S A (1990) 0.88
Chlorpyrifos releases norepinephrine from adult and neonatal rat brain synaptosomes. Brain Res Dev Brain Res (1999) 0.88
Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms. Nicotine Tob Res (2001) 0.88
Cellular determinants of reduced adaptability of the aging brain: neurotransmitter utilization and cell signaling responses after MDMA lesions. Brain Res (2000) 0.88
Cholinergic receptors in heart and brainstem of rats exposed to nicotine during development: implications for hypoxia tolerance and perinatal mortality. Brain Res Dev Brain Res (1999) 0.88
Non-neurogenic mechanism for reserpine-induced release of catecholamines from the adrenal medulla of neonatal rats: possible modulation by opiate receptors. Neuroscience (1982) 0.87
Development of central control of norepinephrine turnover and release in the rat heart: responses to tyramine, 2-deoxyglucose and hydralazine. Neuroscience (1981) 0.87
Beta-adrenoceptor signaling in the developing brain: sensitization or desensitization in response to terbutaline. Brain Res Dev Brain Res (2001) 0.86
Prenatal dexamethasone exposure causes loss of neonatal hypoxia tolerance: cellular mechanisms. Pediatr Res (1994) 0.86
Atypical regulation of hepatic adenylyl cyclase and adrenergic receptors during a critical developmental period: agonists evoke supersensitivity accompanied by failure of receptor down-regulation. Pediatr Res (1996) 0.86
Ontogeny of (--)-[3H]norepinephrine uptake properties of synaptic storage vesicles of rat brain. Brain Res (1978) 0.86
Effects of interleukin-1 infused into brain are antagonized by alpha-MSH in a dose-dependent manner. Eur J Pharmacol (1991) 0.86
Glucocorticoids and the development of neuronal function: effects of prenatal dexamethasone exposure on central noradrenergic activity. Biol Neonate (1992) 0.86
Perinatal exposure to environmental tobacco smoke induces adenylyl cyclase and alters receptor-mediated cell signaling in brain and heart of neonatal rats. Brain Res (2001) 0.86
Prenatal nicotine exposure impairs beta-adrenergic function: persistent chronotropic subsensitivity despite recovery from deficits in receptor binding. Brain Res Bull (1990) 0.85
In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients. Psychiatry Res (1992) 0.85
Intracerebroventricular infusion of interleukin 1 rapidly decreases peripheral cellular immune responses. Proc Natl Acad Sci U S A (1989) 0.85
Impact of soil movement on carbon sequestration in agricultural ecosystems. Environ Pollut (2002) 0.85
Impact of fetal nicotine exposure on development of rat brain regions: critical sensitive periods or effects of withdrawal? Brain Res Bull (1993) 0.84
Cryptic brain cell injury caused by fetal nicotine exposure is associated with persistent elevations of c-fos protooncogene expression. Brain Res (1997) 0.84
Non-neurogenic adrenal catecholamine release in the neonatal rat: exocytosis or diffusion? Brain Res (1986) 0.84
Cocaine acutely inhibits DNA synthesis in developing rat brain regions: evidence for direct actions. Brain Res (1990) 0.84
Promotional role for glucocorticoids in the development of intracellular signalling: enhanced cardiac and renal adenylate cyclase reactivity to beta-adrenergic and non-adrenergic stimuli after low-dose fetal dexamethasone exposure. J Dev Physiol (1992) 0.84
Altered development of basal and forskolin-stimulated adenylate cyclase activity in brain regions of rats exposed to nicotine prenatally. Brain Res Dev Brain Res (1992) 0.83
Oxidation phenotype and metiamide metabolism [proceedings]. Br J Pharmacol (1979) 0.83
Stimulation of ornithine decarboxylase by histamine or norepinephrine in brain regions of the developing rat: evidence for biogenic amines as trophic agents in neonatal brain development. Life Sci (1983) 0.83
Differential diagnosis and pathophysiology of Cushing's syndrome and primary affective disorder. J Neuropsychiatry Clin Neurosci (1990) 0.83
Cortisol responses following placebo and alcohol in Asians with different ALDH2 genotypes. J Stud Alcohol (1994) 0.83